A Phase 1 Study to Evaluate MEDI6383 Alone and in Combination With MEDI4736 in Adult Subjects With Select Advanced Solid Tumors

NCT02221960 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Recurrent or Metastatic Solid Tumors

Interventions

BIOLOGICAL: MEDI6383
BIOLOGICAL: MEDI6383 and MEDI4736

Sponsor

MedImmune LLC